Modern Healthcare July 1, 2020
The Trump administration rolled out new vertical merger guidelines, but experts warn they don’t do enough to prevent anticompetitive mergers and acquisitions in the healthcare industry.
Officials from the Department of Justice and Federal Trade Commission signed off on the long-awaited policy Tuesday. But the final guidance does little to calm the concerns of legal experts, researchers, small providers, consumer advocates and others concerned that vertical mergers harm competition in the healthcare industry. The 14-page document suggests federal regulators will generally view vertical mergers as pro-competitive, even though there’s little proof they improve competition and considerable evidence to the contrary.
“Massive integrated healthcare companies now control nearly all aspects of the healthcare and pharmacy supply chain,” National Community Pharmacists Association...
Today's Sponsors
Today's Sponsor